|Bid||251.64 x 800|
|Ask||251.82 x 900|
|Day's Range||247.36 - 252.76|
|52 Week Range||210.94 - 321.70|
|Beta (3Y Monthly)||0.84|
|PE Ratio (TTM)||99.31|
|Earnings Date||Aug 7, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||287.50|
SAN CLEMENTE, Calif., July 17, 2019 -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion.
ICU Medical, Inc. (ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced that Scott E. Lamb, its Chief Financial Officer and Treasurer, has informed the Company of his intention to retire from the Company effective after filing the FY2019 10-K, following over 16 years of service with the Company. “On behalf of the Board and our entire Company, I would like to thank Scott for his dedication and many significant contributions. Following the change, current Corporate Vice President, Brian Bonnell will be promoted to Chief Financial Officer and Treasurer.
For many, the main point of investing in the stock market is to achieve spectacular returns. While not every stock...
Hedge funds and other investment firms that we track manage billions of dollars of their wealthy clients' money, and needless to say, they are painstakingly thorough when analyzing where to invest this money, as their own wealth also depends on it. Regardless of the various methods used by elite investors like David Tepper and David […]
ICU Medical Inc NASDAQ/NGS:ICUIView full report here! Summary * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is low for ICUI with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding ICUI totaled $94 million. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Small-caps and large-caps are wildly popular among investors, however, mid-cap stocks, such as ICU Medical, Inc...
ICU Medical (ICUI) delivered earnings and revenue surprises of 18.35% and 4.13%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
On a per-share basis, the San Clemente, California-based company said it had profit of $1.44. Earnings, adjusted for one-time gains and costs, were $2.58 per share. The medical device maker posted revenue ...
SAN CLEMENTE, Calif., May 09, 2019 -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy.
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Vivek Jain has been the CEO of ICU Medical, Inc. (NASDAQ:ICUI) since 2014. This analysis a...
ICU Medical (ICUI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Higher revenues, solid segmental performance and strong adjusted gross margins benefit CONMED's (CNMD) Q1 earnings. However, high long-term debt remains a concern.
Higher revenues, growth in APAC and strong operating margin benefit Baxter's (BAX) Q1 earnings. However, weak performance at Medication Delivery and Clinical Nutrition remains a concern.
Boston Scientific (BSX) is investing in new technologies and the global markets, which in turn, aids the uptick in sales across its most geographies in Q1.
Higher revenues, solid segmental performance and strong adjusted gross margins benefit Merit Medical's (MMSI) Q1 earnings. However, higher expenses remain a concern.
Higher revenues, solid segmental performance and strong organic growth across businesses benefit Stryker's (SYK) Q1 earnings.
Quest Diagnostics (DGX) currently concentrates on its core diagnostic information services business and tries to maintain discipline in capital deployment.